no statement of use filed
on 04 Mar 2024
Last Applicant/ Owned by
HAIDIAN DISTRICT
BEIJING
CN
100094
Serial Number
90265690 filed on 20th Oct 2020
Registration Number
N/A
Correspondent Address
Leo M. Loughlin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"DIAGNOSTICS CORPORATION"
"DIAGNOSTICS CORPORATION" Medical devices for use in treating or diagnosing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Hematology analyzers for medical diagnostic useRead More
Medical devices for use in treating or diagnosing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Hematology analyzers for medical diagnostic uses; Medical diagnostic apparatus for detecting cancer; Diagnostic apparatus for the detection of cancer; Medical instrument for cardiovascular diagnostics; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic apparatus for testing DNA, protein, Antigen, antibody, whole blood, serum and plasma; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical apparatus and instruments for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCH
Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic reagents and contrast media for medical use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic reagents for medicinal use; Diagnostic preparations for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposes; Pharmaceutical preparations for medical purposes for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCH
No 90265690
No Service/Collective Mark
No 4771-104
No
No
No
No
No
No
No
No
01.15.08 -
A single drop (including a single raindrop or a single teardrop)
The mark consists of the stylized wording "CHIVD CHEMCLIN DIAGNOSTICS CORPORATION" with a water drop design inside of the letter "v".
| Status Date | Action Taken |
|---|---|
| 04th Mar 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 04th Mar 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 24th May 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd May 2023 | SOU TEAS EXTENSION RECEIVED |
| 22nd May 2023 | SOU EXTENSION 4 FILED |
| 22nd May 2023 | SOU EXTENSION 4 GRANTED |
| 20th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Jan 2023 | SOU TEAS EXTENSION RECEIVED |
| 18th Jan 2023 | SOU EXTENSION 3 FILED |
| 18th Jan 2023 | SOU EXTENSION 3 GRANTED |
